Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Link to Dutton 10-21-08 Research Note

The value added to this company in the past year

has not positively affected the SP but in contrast

reduced shareholder value dramatically and the only

legitimate reason given is the USPTO.

When will this blackout be lifted so the SH can begin to share

some of the wealth and we can become a real company.

Share
New Message
Please login to post a reply